Page 255 - Timeliness of Infectious Disease Notification & Response Systems - Corien Swaan
P. 255
45: Morré SA, Catsburg A, de Boer M, Spaargaren J, de Vries HJ, Schirm J, Savelk- oul PH, van Steenbergen J, Swaan C. Monitoring the potential introduction of the Swedish Chlamydia trachomatis variant (swCT) in the Netherlands. EuroSur- veill. 2007 Oct 1;12(10):E9-E10.
46: Swaan CM, van der Sande MA, Speelman P, Conyn-van Spaendonck MA, Straus SM, Coutinho RA. [Adverse events following influenza vaccination: reac- tion to specific reports and the necessity of a central registration system]. Ned Tijdschr Geneeskd. 2007 Sep 29;151(39):2166-9. Dutch.
47: Tjon GM, Coutinho RA, van den Hoek A, Esman S, Wijkmans CJ, Hoebe CJ, Wolters B, Swaan C, Geskus RB, Dukers N, Bruisten SM. High and persistent excretion of hepatitis A virus in immunocompetent patients. J Med Virol. 2006 Nov;78(11):1398-405.
48: Swaan CM, van den Broek PJ, Kampert E, Berbée GA, Schippers EF, Beersma MF, Wijnands S. Management of a patient with Lassa fever to prevent transmis- sion. J Hosp Infect. 2003 Nov;55(3):234-5.
49: van Dam AP, Schippers EF, Visser LG, Peek N, Swaan CM, Kuijper EJ. [A case of diphtheria in the Netherlands due to an infection with Corynebacterium ul- cerans].Ned Tijdschr Geneeskd. 2003 Mar 1;147(9):403-6. Dutch.
50: Visser LG, Schippers EF, van den Broek PJ, Swaan CM. [How to treat a patient with indications for an infectious viral hemorrhagic fever]. Ned Tijdschr Genees- kd. 2003 Feb 1;147(5):221-2. Dutch.
51: Swaan CM, van den Broek PJ, Wijnands S, van Steenbergen JE. Management of viral haemorrhagic fever in the Netherlands. Euro Surveill. 2002 Mar;7(3):48- 50. Review.
52: Visser LG, Schippers EF, Swaan CM, van den Broek PJ. [How to treat a pa- tient with indications for an infectious viral hemorrhagic fever]. Ned Tijdschr Geneeskd. 2002 Nov 16;146(46):2183-8. Review. Dutch.
53: Swaan CM, Blok L. Privation and injustice in North Korea. Lancet. 1999 Feb 6;353(9151):503-4.
Publications 253